The application health care company under the control of Carl has been developing smoothly because of its strong partnership. Its main product, Band-Aid, has now become a must-have spare for American families, but has also gone abroad. After the factory of the company's German partner, Byelsteuff, was put into production, the Bondy brand quickly became a well-known brand in European countries. Byelsteuff also came back from this. The company was almost grateful for the cooperation. Chairman Clawson even made a special trip to California to express his gratitude. This action brought the distance between the two companies very well, laying a certain foundation for the entire Byelsteuff to integrate into the application health care system in the future.

After the sales of Band-Aids are stable, it is naturally necessary to open up a new product line. This is in Evan's plan. After the establishment of the board of directors, Evan officially helped Carl as the head of Applied Healthcare Company. Under Carl's leadership, Applied Healthcare Company continued to move. First, it reached a cooperative relationship with several medical schools within the University of California system, and then invested a lot of money to establish its own medical institute and healthcare institute. As the name suggests, the former focuses on medical and drug research, while the latter develops healthcare products. By the way, only the latter of these two institutes is in Los Angeles, while the former was installed in Sacramento, and the office address was exactly where the Chester Laboratory was originally located.

During the establishment of the institute, Jesse House, the Warren family doctor, made great efforts. If it weren't for his relationship, even if the Applied Healthcare Company had money, it would not have been possible to find so many qualified medical research talents in a short period of time.

Of course, as we all know, it takes a certain amount of time to invest in R&D to output. In the field of medicine, this time is even more uncertain than other fields.

Therefore, in order not to stagnate the development of applied health care companies, Evan once again "lighted inspiration" and provided Carl with a creativity.

The finished product of this creative is the diapers used by Carl's daughter Jenny now.

Diapers are a must-have item for every new family in modern society. As a substitute for traditional diapers, it can save parents a lot of trouble, so that they don’t have to worry about clothes that are not replaced after their children are wet.

Diapers as a creative idea were actually not the first to create Evan. In fact, the first to try diapers substitutes was the Japanese. The reason was very simple. During World War II, Japan lacked natural supplies. The Swedish Boris Telm took a substantial step. In 1942, he invented a two-piece diaper, with plastic pants on the outer layer and wrinkled toilet paper absorbing pads. However, because the paper absorbing pads are too easy to break and debris will fill the child's butt, it has not been widely used.

Of course, Evan gave the solution without this problem. The absorbent he suggested was a polymer absorber. In order to find qualified polymers, the Applied Health Care Company simply set up a chemistry laboratory and hired digital chemists, several of which were from Germany and were recruited by the introduction of Clawson, chairman of Byelsteulf.

With the support of large amounts of funds, the research and development cycle of diapers only took less than half a year before it achieved results, and the use effect was pretty good. After Evan's approval, diapers have entered the stage of preparation for mass production. According to the current progress, it is estimated that it will be until October this year.

Therefore, every diaper Jenny uses is valuable now because it is not a product.

After having Jenny, Carl never doubted the market prospects of diapers. He even felt that diapers are of no less valuable than Band-Aids.

But even so, Carl is still working hard to build the company's own R&D team, because this is the guarantee that the company can continue to launch new products.

After combining the suggestions of experts such as Evan and House, the Institute of Medicine of Applied Healthcare, combined with the research preferences of the talents recruited, it determined several major research priorities, namely heart disease drugs, hypertension drugs, diabetes drugs and polio vaccines.

Needless to say, the vaccine Carl came to find Evan today refers to the polio vaccine.

This research direction was designated by Evan.

Speaking of polio, it can be said that it is discolored in this era. This acute infectious disease, scientifically called polio, is caused by the polio virus, which can cause serious harm to children's health, has caused huge losses to the United States. The biggest victim was former US President Roosevelt. With the end of World War II, the United States ushered in a post-war prosperity and the population entered a stage of rapid growth. With the increase of infants, the number of victims of polio began to break out. In 1946, the United States reported a total of more than 20,000 cases nationwide, and in 1950, this number doubled.

If this continues, more and more children will suffer.

Faced with this situation, American mothers decided to declare war on polio. They intended to solve this problem through various methods, including setting up funds, lobbying government departments, etc.

So far, there is a fundraising campaign called "Mother Polio Operation", which has started last year, which has raised tens of millions of funds and has not stopped.

And this action was exactly the reason why Evan convinced Carl to include polio as the focus of the institute.

Evan not only made suggestions, but also recommended an expert in this area to Carl. This person is the Sabin that Carl just mentioned, named Albert Sabin.

Polio is caused by viruses. To solve it, the best way is to use vaccines to prevent and treat it. Someone has done this work after clarifying the cause of polio. According to the type of vaccine, the current research is divided into two routes: one is an inactivated vaccine and the other is an inactivated vaccine. The former is led by Jonas Salk of the University of Pittsburgh, and the latter is an advocate of Albert Sabin of Cincinnati.

In principle, inactivated vaccines are better choices than deactivated vaccines, whether in terms of safety or research difficulty. This is why Carl came to Evan today.

He wondered why Evan chose to support the latter's research.

"There are three reasons..." In the face of Carl's questioning, Evan replied slowly: "First, Salk not only has the support of the National Foundation, but also has ten pharmaceutical factories watching, so it is difficult for us to intervene;"

"Secondly, the production conditions of inactivated vaccines are very high, and we lack relevant experience and technology. Of course, you can say that it will take a long time to successfully develop a vaccine. This period is enough for us to prepare for production conditions. Well, if you think so, then just pretend that I didn't say this;"

“The third and most important point is that I think Sabin’s route is more secure.”

Evan dared to draw this conclusion because he had "history" as the basis for judgment.

"Although Salk's vaccine was successful first, it became a virus because of the underestimation of the difficulty of inactivated viruses. It artificially created a virus outbreak, known in history as the 'Carter Tragedy'."
Chapter completed!